It is a pharma private limited company based in Vadodara, Gujarat, India, established in 2020.
2020 | Vadodara, Gujarat, India | ActiveDiocard Pharmaceuticals Private Limited, a active private limited company, was established on 10 October 2020 in Vadodara, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U85300GJ2020PTC117210. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Employing 7 professional, Its leadership includes Pankaj Patel (Director), Krushiraj Chinubhai Patel (Director). Past directors included Ripalkumar Kishorbhai Shah, Rikeetaben Shah, Rokykumar Jayeshbhai Patel. It holds ₹1.74 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No-313, K P Landmark, Nr. Bright School Bhayli Road,, Vadodara, Gujarat, 391410.
U85300GJ2020PTC117210
117210
10 October 2020
₹0.50 M
₹0.50 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Diocard Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pankaj Patel | Director | 05 Aug 2021 | Current |
| Krushiraj Chinubhai Patel | Director | 05 Aug 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Aug 2024 | Past |
| Pramod Abcsdd | Director | 01 Aug 2024 | Past |
| Pramod Abcsdd | Director | 10 Aug 2021 | Past |
| Pramod Abcsdd | Director | 10 Aug 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Diocard Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 69.31% increase. The company also saw a substantial improvement in profitability, with a 37.59% increase in profit. The company's net worth Soared by an impressive increase of 78.03%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Diocard Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹1,735,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Sep 2022 | Others | ₹1.74 M | Open |
Explore comprehensive loan charge details -
Diocard Pharmaceuticals has a workforce of 7 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Diocard Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diocard Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Diocard Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Diocard Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
A charge with Others amounted to Rs. 1.74 M with Charge ID 100625794 was registered on 29 Sep 2022. was recorded as a recent event.
Progress on Pankaj Patel was appointed as a Director was appointed as a Director on 05 Aug 2021 & has been associated with this company since 4 years 3 months . was documented.
Krushiraj Chinubhai Patel was appointed as a Director was appointed as a Director on 05 Aug 2021 & has been associated with this company since 4 years 3 months . was recorded as a recent event.
Diocard Pharmaceuticals Private Limited was registered on 10 Oct 2020 with Roc Ahmedabad & aged 5 years 1 month as per MCA records. was recorded as a recent event.
The CIN of Diocard Pharmaceuticals Private Limited is U85300GJ2020PTC117210.
Diocard Pharmaceuticals Private Limited is headquartered at Office No-313, K P Landmark, Nr. Bright School Bhayli Road,, Vadodara, Gujarat, 391410.
Diocard Pharmaceuticals Private Limited was incorporated on 10 October 2020.
The current directors of Diocard Pharmaceuticals Private Limited are
The primary industry of Diocard Pharmaceuticals Private Limited is Manufacturing.
Diocard Pharmaceuticals Private Limited is unlisted.
The authorized capital of Diocard Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Diocard Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX